- Poster Presentation
- Open Access
ColE1 derived RNA I as a key molecule in a novel antibiotic free plasmid addiction system
© Pfaffenzeller et al; licensee BioMed Central Ltd. 2006
- Published: 10 October 2006
- Essential Gene
- Antibiotic Resistance Gene
- Recombinant Protein Production
- Plasmid Replication
- Replication Machinery
Consequently, the strategy presented in this work can be applied for conventional protein expression vectors as well as for therapeutical plasmids.
In our experiments we found that RNA I was capable of silencing engineered target genes by RNA antisense reaction completely. On the mRNA transcript of the reporter gene gfp (green fluorescent protein) RNA II-like sequences were added near the ribosomal binding site. Thus, suppression of a chromosomally inserted gfp gene could be achieved by mere presence of the ColE1-type plasmid pBR322 in shaker flask experiments and fed-batch fermentation processes.
Conditionally lethal bacterial hosts were created by inserting an inducible promoter on the genome in front of an essential gene, e.g. murA  by homologous recombination . By integration of an IPTG inducible expression cassette on the bacterial genome containing the tet-repressor gene (tetR), we were able to inhibit growth upon addition of IPTG, when the essential gene was set under control of the corresponding promoter, pLtetO .
For the design of engineered hosts depending on a ColE1-type plasmid in the cell the tetR transcript was combined with RNA I complementary sequences. Thus, the plasmid's replication machinery provides an essential advantage to the host cells.
Basically, the discrete reactions of the plasmid addiction system were proven to be functional. We demonstrated that the regulatory mechanism of ColE1 plasmid replication is a useful tool for gene silencing of a designed target gene. Moreover, the essential gene murA was shown to be an efficient target for the selection system.
The strategy of regulating gene expression by plasmid replication implicates a novel strategy for plasmid selection in recombinant protein production processes and for gene therapeutic applications.
This work was funded by Boehringer Ingelheim Austria.
- Studier W, Moffatt BA: Use of the bacteriophage T7 RNA polymerase to direct selective high level expression of cloned genes. J Mol Biol. 1986, 189: 113-130. 10.1016/0022-2836(86)90385-2.View ArticleGoogle Scholar
- Herring D, Blattner FR: Conditional lethal amber mutations in essential Escherichia coli genes. J Bacteriol. 2004, 186 (9): 2673-2681. 10.1128/JB.186.9.2673-2681.2004.View ArticleGoogle Scholar
- Datsenko A, Wanner BL: One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. PNAS. 2000, 97 (12): 6640-6645. 10.1073/pnas.120163297.View ArticleGoogle Scholar
- Lutz R, Bujard H: Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory systems. Nucleic Acids Res. 1997, 25 (6): 1203-1210. 10.1093/nar/25.6.1203.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd.